意大利儿科专家关于诊断和治疗原发性亚托皮性疾病的共识声明
Fabio Cardinale1, Ivan Taietti2,3, Mayla Sgrulletti4
1Department of Pediatrics, Regional Referral Center in Pediatric Allergy, Immunology and Rheumatology, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy.
概括
主要的无氧性疾病 (PAD) 是导致严重过敏的免疫系统疾病. 这种共识为诊断和管理提供了指导方针,通过早期,个性化的治疗来改善结果.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 儿科过敏 儿科过敏
背景情况:
- 初级无源性疾病 (PAD) 是一组独特的先天性免疫错误 (IEI).
- PAD涉及严重的亚托皮,失调的2型免疫,巨细胞激活和高IgE.
- 患者经常出现湿疹,喘,食物过敏和eosinophilic胃肠道疾病.
研究的目的:
- 制定PAD的标准化诊断和管理指南.
- 解决在儿科过敏和免疫学中对PAD进行结构化的方法的需要.
- 在临床实践中改善PAD的识别和治疗.
主要方法:
- 意大利儿科过敏和免疫学学会 (SIAIP) 制定了基于德尔菲的专家共识.
- 涉及到一个系统的文献审查和45名儿科子专家之间的协议.
- 专注于PAD的分类,诊断工作和治疗策略.
主要成果:
- 在临床环境中怀疑PAD的红旗.
- 建议的诊断途径,以区分单基性PAD和多基性过敏状况.
- 突出了精准医学的分子途径分析,包括生物制剂,并建议采用多学科方法.
结论:
- 这是第一个结构化的共识,用于在儿科子专业中标准化PAD诊断和管理.
- 旨在通过早期识别和量身定制的治疗策略来提高患者的治疗结果.
- 将遗传发现集成到临床实践中,以提供个性化的PAD护理.
相关概念视频
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
COPD: Management Using Bronchodilators and Corticosteroids
713
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
713


